Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients

Canadian Journal of Anesthesia

Volumn 48, Issue 11, 2001, Pages 1155-1160

  Ferring, Martine ^a   Reber, Guide ^b   de Moerloose, Philippe ^b   Merlani, Paolo ^a   Diby, Marc ^a   Ricou, Ricou ^a  

^a Hemostasis unit   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APROTININ; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; HEPARIN; PROTAMINE;

ABDOMINAL SURGERY; ADULT; AGED; APPARATUS; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD SAMPLING; CARDIOVASCULAR SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; INTENSIVE CARE; INTERMETHOD COMPARISON; LABORATORY TEST; MALE; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; VOLUNTEER;

ABDOMEN; AGED; CARDIAC SURGICAL PROCEDURES; FACTOR XA; FEMALE; HUMANS; INTENSIVE CARE; LABORATORY TECHNIQUES AND PROCEDURES; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 0035570319     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03020384     Document Type: Article

References (20)

1. Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: A coronary unit experience
2. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation
3. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction. Results from the GUSTO-I trial
4. Point-of-care (POC) measurement of coagulation after cardiac surgery
5. Bedside monitoring of heparin therapy: Comparison of activated clotting time to activated partial thromboplastin time
6. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus® in various clinical settings
7. The diagnostic accuracy of bedside and laboratory coagulation. Procedures used to monitor the anticoagulation status of patients treated with heparin
8. Comparison of bedside coagulation monitoring tests with standard laboratory tests in patients after cardiac surgery
9. Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin III
10. Statistical methods for assessing agreement between two methods of clinical measurement
11. Measurement of the activated partial thromboplastin time from a capillary (fingerstick) sample of whole blood. A new method for monitoring heparin therapy
12. Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: Results of GUSTO-I
13. A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease
14. New bedside test for monitoring anticoagulation during hemodialysis
15. Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass
16. Determination of normal versus abnormal activated partial thromboplastin time and prothrombin time after cardiopulmonary bypass
17. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery
18. Comparison of activated partial thromboplastin time reagents
19. The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagent produced by the same manufacturer
20. Effect of analytic uncertainty of conventional and point-of-care assays of activated partial thromboplastin time on clinical decisions in heparin therapy